Achieve Life Sciences ACHV Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's stock issuance proceeds?
- Achieve Life Sciences (ACHV) reported stock issuance proceeds of $0 in Q4 2025.
- How has Achieve Life Sciences's stock issuance proceeds changed year-over-year?
- Achieve Life Sciences's stock issuance proceeds decreased by 100.0% year-over-year, from $44.5K to $0.
- What is the long-term trend for Achieve Life Sciences's stock issuance proceeds?
- Over 2 years (2022 to 2025), Achieve Life Sciences's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $126K to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.